United Kingdom Capsule Endoscopy Market Size, Share, and COVID-19 Impact Analysis, By Type (Small Bowel Capsule Endoscopy, Esophageal Capsule Endoscopy, Colon Capsule Endoscopy, and Others), By Application (OGIB (obscure GI tract bleeding), Crohn’s disease, Small Intestine tumor, Others (Celiac, andNSAID reactions)), and United Kingdom Capsule Endoscopy Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Capsule Endoscopy Market Size Insights Forecasts to 2035

• The United Kingdom Capsule Endoscopy Market Size was estimated at USD 20.22 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.22% from 2025 to 2035
• The United Kingdom Capsule Endoscopy Market Size is Expected to Reach USD 43.55 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Capsule Endoscopy Market Size is anticipated to reach USD 43.55 Million by 2035, Growing at a CAGR of 7.22% from 2025 to 2035. The Market Size is primarily driven by the invention of technologically improved capsule endoscopes, increasing demand for minimally invasive diagnostic procedures, and the increasing incidence of cancers of the colon and gastrointestinal (GI) illnesses.

Market Overview

The United Kingdom capsule endoscopy market refers to the subsector of healthcare industry with medical device industry dedicated to the creation, manufacturing, and distribution of capsule endoscopy systems, which are minimally invasive diagnostic instruments that use a wireless camera capsule the size of a pill to inspect the gastrointestinal (GI) tract, particularly regions that are difficult to access with conventional endoscopes. A medical treatment called capsule endoscopy allows doctors to visually inspect the whole gastrointestinal tract and spot any unfavorable symptoms. As the name implies, capsule endoscopy is a technological marvel that takes advantage of the size of the capsule. It is designed to pass through the digestive system, capture photographs of the entire system, and transmit those images to a wireless transmitter. In modern medicine, capsule endoscopy makes it possible for a less intrusive, faster, and less expensive diagnostic technique. Contrary to traditional endoscopy, it enables doctors to get closer by reaching the interior sections of the intestines. The procedure is painless, and recent developments in medicine have produced more affordable, improved capsule endoscopy, which is driving the market's expansion. Adoption in the UK is also greatly accelerated by the National Health Service's (NHS) efforts to use digital diagnostics, extended GI screening programs, and investments in telemedicine and outpatient services.

Report Coverage

This research report categorizes the market for the United Kingdom capsule endoscopy market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom capsule endoscopy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom capsule endoscopy market.

Driving Factors

The market for the United Kingdom capsule endoscopy is driven by the development of the healthcare infrastructure to lessen and ultimately alleviate these expenses is being facilitated by the government. The market will continue to increase as a result of innovations and technological advancements. Furthermore, a number of significant reasons are driving the market's expansion, including the presence of developed economies, high disposable income, established healthcare infrastructure, and the availability of qualified specialists. The growing incidence of gastrointestinal (GI) disorders, the high demand for minimally invasive diagnostic technologies, continuous technological advancements (particularly in imaging quality, AI-assisted diagnostics, and device battery life), and growing public awareness of early GI disease and cancer detection are the main factors propelling the UK capsule endoscopy market.

Restraining Factors

The market expansion could be restricted due to the high equipment and operating costs, issues with data integration, restrictive reimbursement regulations, and the NHS's and commercial insurers' uncertain or limited coverage of capsule endoscopy operations.

Market Segmentation

The United Kingdom capsule endoscopy market share is classified into type and application.

• The colon capsule endoscopy segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The United Kingdom capsule endoscopy market is segmented by type into small bowel capsule endoscopy, esophageal capsule endoscopy, colon capsule endoscopy, and others. Among these, the colon capsule endoscopy segment held a significant share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The market is expanding colon screening and raising awareness of colon cancer. Further driving market expansion are the deployment of critical screening programs for accurate cancer diagnosis, the rapid technological improvements in capsule endoscopy, the growing demand for less invasive operations, and the rising disposable income.

• The small intestine tumor segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The United Kingdom capsule endoscopy market is segmented by application into OGIB (obscure GI tract bleeding), Crohn’s disease, small intestine tumor, and others (Celiac, and NSAID reactions).

Among these, the small intestine tumor segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. This segment is growing as a result of the growing importance of capsule endoscopy in the safe and noninvasive identification of small intestine cancers and associated conditions. Additionally, the use of capsule endoscopy in the treatment of small intestinal malignancies has been highlighted by clinical initiatives.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom capsule endoscopy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic
• Olympus Corporation
• EndoChoice (Acquired by Boston Scientific)
• Capsule Endoscopy UK
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom capsule endoscopy market based on the below-mentioned segments:

United Kingdom Capsule Endoscopy Market, By Type

• Small Bowel Capsule Endoscopy
• Esophageal Capsule Endoscopy
• Colon Capsule Endoscopy
• Others

United Kingdom Capsule Endoscopy Market, By Application

• OGIB (obscure GI tract bleeding)
• Crohn’s disease
• Small Intestine tumor
• Others (Celiac, and NSAID reactions)